$Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report$

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report

Abstract Background Pregnancy is an unquantifiable risk to accelerate tumor growth of papillary thyroid carcinoma (PTC), and whether pregnancy induces an unfavorable prognosis of radioiodine refractory papillary thyroid carcinoma (RR-PTC) remains unknown. Case presentation We investigated the impact...

Full description

Bibliographic Details
Main Authors:	Yuchen Jin, Min Liu, Lingxiao Cheng, Libo Chen
Format:	Article
Language:	English
Published:	BMC 2017-11-01
Series:	BMC Cancer
Subjects:	Radioiodine refractory papillary thyroid carcinoma Pregnancy Prognosis Thyroid stimulating hormone Thyroglobulin
Online Access:	http://link.springer.com/article/10.1186/s12885-017-3717-3

Similar Items

A user-friendly nomogram for predicting radioiodine refractory differentiated thyroid cancer
by: Chao Meng, et al.
Published: (2023-02-01)

The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer
by: Carla Colombo, et al.
Published: (2020-11-01)

TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer
by: Nianting Ju, et al.
Published: (2023-06-01)

Blood Profiles in the Prediction of Radioiodine Refractory Papillary Thyroid Cancer: A Case–Control Study
by: Liu H, et al.
Published: (2023-02-01)

Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
by: Ri Sa, et al.
Published: (2020-11-01)

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
by: Hsi-Chen Tsai, et al.
Published: (2022-01-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
by: Urbano Anido Herranz
Published: (2022-10-01)

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na<sup>+</sup>/I<sup>−</sup> Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells
by: Thoudam Debraj Singh, et al.
Published: (2023-02-01)

Evaluation value of ultrasound imaging combined with serum index in the invasion of papillary thyroid carcinoma
by: GU Yaoyao*, NI Xuejun, YANG Qingrong, YU Xiaodi
Published: (2023-11-01)

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
by: M. S. Brose, et al.
Published: (2018-07-01)

Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
by: Genpeng Li, et al.
Published: (2018-11-01)

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
by: Elisa Minaldi, et al.
Published: (2023-01-01)

Prognostic factors for postoperative papillary thyroid cancer with unexplained elevated Tg: A retrospective study
by: Chenghui Lu, et al.
Published: (2024-03-01)

Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
by: Dario Tumino, et al.
Published: (2017-11-01)

The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes
by: Jingjia Cao, et al.
Published: (2023-12-01)

Value of follow-up diagnostic radioiodine scans in differentiated thyroid cancer
by: Teresa Kraus, et al.
Published: (2024-04-01)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
by: Chae Moon Hong, et al.
Published: (2017-10-01)

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
by: Jaume Capdevila, et al.
Published: (2023-08-01)

Progress on Targeted Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
by: TENG Lisong, et al.
Published: (2023-05-01)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
by: Maaike Dotinga, et al.
Published: (2022-12-01)

Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
by: E. V. Borodavina, et al.
Published: (2024-08-01)

Effect of therapeutic radioiodine activity on ablation response in differentiated thyroid cancer patients with cut-off serum thyroglobulin levels after 2 weeks of thyroid hormone withdrawal: a retrospective study
by: Ji Young Lee, et al.
Published: (2022-12-01)

Clinical use of lenvatinib in patients with previous renal and/or hepatic impairment and radioiodine‐refractory differentiated thyroid cancer
by: Javier Martínez‐Trufero
Published: (2022-10-01)

Preoperative, operative, and postoperative pathological features in thyroid papillary carcinoma with and without capsule invasion
by: Burak Uçaner, et al.
Published: (2024-03-01)

Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
by: Pedro Weslley Rosario, et al.

The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease
by: Zhang Ling, et al.
Published: (2012-12-01)

Progress in Re-differentiating Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
by: ZHANG Yaqi, et al.
Published: (2022-10-01)

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
by: Hee Kyung Kim, et al.
Published: (2020-09-01)

Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors
by: Tetiana Bogdanova, et al.
Published: (2024-01-01)

Non-thyroidal second primary malignancy in papillary thyroid cancer patients
by: Diana Borges Duarte, et al.
Published: (2023-01-01)

Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid Cancer
by: Justus Baumgarten, et al.
Published: (2022-05-01)

The role of anti-TPO as an additional analytical marker in thyroid disease patients in Erbil City
by: Ronia Shawkat Kawther ,, et al.
Published: (2022-12-01)

The influence of thyroid status, serum Tg, TSH, and TgAb on FNA‐Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma
by: Jingjing Sun, et al.
Published: (2022-02-01)

Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment
by: Andre Ywata de Carvalho, et al.
Published: (2024-06-01)

Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
by: Xu Bin, et al.
Published: (2023-08-01)

Radioiodine ablation after thyroidectomy could be safely abandoned or postponed in selected stage I papillary thyroid carcinoma patients of low-risk group: an observational prospective study
by: S.M. Cherenko, et al.
Published: (2024-03-01)

Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice
by: P. O. Rumyantsev, et al.
Published: (2021-11-01)

Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
by: Cristiane J. Gomes-Lima, et al.
Published: (2021-02-01)

The application of nanocarbon tracer in the surgical treatment of papillary thyroid microcarcinoma
by: LIU Jun, DU Bin, WANG Yu, DONG Jun, CUI Fengming
Published: (2023-11-01)